Nutrition in patients on peritoneal dialysis

Nature Reviews Nephrology

Volumn 8, Issue 3, 2012, Pages 163-175

  Han, Seung Hyeok ^a   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; ESSENTIAL AMINO ACID; GHRELIN; HUMAN GROWTH HORMONE; MEGESTROL ACETATE; NANDROLONE DECANOATE; OXYMETHOLONE; PLACEBO; RECOMBINANT SOMATOMEDIN C;

ACIDOSIS; ADRENAL INSUFFICIENCY; BODY MASS; CATABOLISM; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; DIALYSATE; DIET THERAPY; DIETARY INTAKE; HEMODIALYSIS PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; LOW DRUG DOSE; MALNUTRITION; METABOLIC ACIDOSIS; MUSCLE MASS; NUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PERIPHERAL EDEMA; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN ENERGY WASTING; REVIEW; THROMBOEMBOLISM; WASTING SYNDROME;

HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITION THERAPY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PROTEIN-ENERGY MALNUTRITION; RISK FACTORS;

EID: 84857788736     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.12     Document Type: Review

References (159)

1. Kang, D. H., Kang, E. W., Choi, S. R., Yoon, S. Y. & Han, D. S. Nutritional problems of Asian peritoneal dialysis patients. Perit. Dial. Int. 23 (Suppl. 2), S58-S64 (2003). (Pubitemid 38100806)
2. Cianciaruso, B. et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am. J. Kidney Dis. 26, 475-486 (1995).
3. Young, G. A. et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am. J. Kidney Dis. 17, 462-471 (1991).
4. Fouque, D. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 73, 391-398 (2008). (Pubitemid 351186278)
5. Dukkipati, R. & Kopple, J. D. Causes and prevention of protein-energy wasting in chronic kidney failure. Semin. Nephrol. 29, 39-49 (2009).
6. Kopple, J. D. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am. J. Kidney Dis. 24, 1002-1009 (1994). (Pubitemid 24380475)
7. Bergstrom, J. Nutrition and mortality in hemodialysis. J. Am. Soc. Nephrol. 6, 1329-1341 (1995).
8. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J. Am. Soc. Nephrol. 7, 198-207 (1996).
9. Dong, J., Li, Y., Xu, Y. & Xu, R. Daily protein intake and survival in patients on peritoneal dialysis. Nephrol. Dial. Transplant. 26, 3715-3721 (2011).
10. Bergstrom, J. Why are dialysis patients malnourished? Am. J. Kidney Dis. 26, 229-241 (1995).
11. Wang, A. Y. et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol. 12, 2450-2457 (2001). (Pubitemid 33021123)
12. Wang, A. Y. & Lai, K. N. The importance of residual renal function in dialysis patients. Kidney Int. 69, 1726-1732 (2006). (Pubitemid 43739198)
13. Chung, S. H., Stenvinkel, P., Lindholm, B. & Avesani, C. M. Identifying and managing malnutrition stemming from different causes. Perit. Dial. Int. 27 (Suppl. 2), S239-S244 (2007). (Pubitemid 350047708)
14. Bossola, M. et al. Malnutrition in hemodialysis patients: what therapy? Am. J. Kidney Dis. 46, 371-386 (2005). (Pubitemid 41208173)
15. Chung, S. H., Carrero, J. J. & Lindholm, B. Causes of poor appetite in patients on peritoneal dialysis. J. Ren. Nutr. 21, 12-15 (2011).
16. Stenvinkel, P., Heimburger, O., Lindholm, B., Kaysen, G. A. & Bergstrom, J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant. 15, 953-960 (2000). (Pubitemid 30410364)
17. Noh, H. et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int. 18, 387-394 (1998). (Pubitemid 28484667)
18. Stenvinkel, P., Chung, S. H., Heimburger, O. & Lindholm, B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit. Dial. Int. 21 (Suppl. 3), S157-S162 (2001). (Pubitemid 34406796)
19. de Mutsert, R. et al. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol. Dial. Transplant. 23, 2957-2964 (2008).
20. Mitch, W. E., Du, J., Bailey, J. L. & Price, S. R. Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines. Miner. Electrolyte Metab. 25, 216-219 (1999). (Pubitemid 30099667)
21. Aguilera, A. et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol. Dial. Transplant. 13, 1476-1483 (1998). (Pubitemid 28254323)
22. Mak, R. H., Cheung, W., Cone, R. D. & Marks, D. L. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 69, 794-797 (2006).
23. Carrero, J. J. et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol. Dial. Transplant. 25, 901-906 (2010).
24. Price, S. R. et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98, 1703-1708 (1996). (Pubitemid 26359185)
25. Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119 (2005).
26. Lee, S. W., Park, G. H., Song, J. H., Hong, K. C. & Kim, M. J. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol. Dial. Transplant. 22, 2554-2562 (2007). (Pubitemid 47365520)
27. Bayraktar, G. et al. Oral health and inflammation in patients with end-stage renal failure. Perit. Dial. Int. 29, 472-479 (2009).
28. Cheng, L. T., Tang, W. & Wang, T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am. J. Kidney Dis. 45, 891-902 (2005). (Pubitemid 43181049)
29. Lai, K. N. & Leung, J. C. Inflammation in peritoneal dialysis. Nephron Clin. Pract. 116, c11-c18 (2010).
30. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am. J. Kidney Dis. 35 (Suppl. 2), S1-140 (2000).
31. Wang, A. Y. et al. Nutrient intake during peritoneal dialysis at the Prince of Wales Hospital in Hong Kong. Am. J. Kidney Dis. 49, 682-692 (2007). (Pubitemid 46654490)
32. Lindholm, B., Wang, T., Heimburger, O. & Bergstrom, J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol. Dial. Transplant. 13 (Suppl. 6), 66-73 (1998). (Pubitemid 28356695)
33. Bazanelli, A. P. et al. Resting energy expenditure in peritoneal dialysis patients. Perit. Dial. Int. 26, 697-704 (2006). (Pubitemid 46196086)
34. Bergstrom, J., Furst, P., Alvestrand, A. & Lindholm, B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int. 44, 1048-1057 (1993). (Pubitemid 23316473)
35. Carrero, J. J. et al. Appetite disorders in uremia. J. Ren. Nutr. 18, 107-113 (2008). (Pubitemid 350251837)
36. Aguilera, A. et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am. J. Kidney Dis. 42, 787-796 (2003). (Pubitemid 37187380)
37. Kalantar-Zadeh, K., Ikizler, T. A., Block, G., Avram, M. M. & Kopple, J. D. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am. J. Kidney Dis. 42, 864-881 (2003). (Pubitemid 37322905)
38. Zheng, Z. H. et al. Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats. Kidney Int. 60, 2392-2398 (2001).
39. Stompor, T. et al. Association between gastric emptying rate and nutritional status in patients treated with continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 22, 500-505 (2002). (Pubitemid 35012267)
40. Van, V. et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit. Dial. Int. 22, 32-38 (2002). (Pubitemid 34326577)
41. Cummings, D. E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719 (2001). (Pubitemid 33641587)
42. Perez-Fontan, M. et al. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol. Dial. Transplant. 19, 2095-2100 (2004). (Pubitemid 39139643)
43. Aguilera, A. et al. Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv. Perit. Dial. 20, 194-199 (2004).
44. Perez-Fontan, M. et al. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int. 68, 2877-2885 (2005). (Pubitemid 43251035)
45. Zheng, Z. H. et al. Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution. Perit. Dial. Int. 29, 656-663 (2009).
46. Blumenkrantz, M. J. et al. Protein losses during peritoneal dialysis. Kidney Int. 19, 593-602 (1981).
47. Kathuria, P. et al. Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis. Perit. Dial. Int. 17, 449-454 (1997). (Pubitemid 27510663)
48. Kang, D. H. et al. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients. Nephrol. Dial. Transplant. 14, 1715-1722 (1999).
49. Pecoits-Filho, R. et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol. Dial. Transplant. 17, 1480-1486 (2002).
50. Churchill, D. N. et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J. Am. Soc. Nephrol. 9, 1285-1292 (1998). (Pubitemid 28283893)
51. Rumpsfeld, M., McDonald, S. P. & Johnson, D. W. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J. Am. Soc. Nephrol. 17, 271-278 (2006).
52. Cueto-Manzano, A. M., Espinosa, A., Hernandez, A. & Correa-Rotter, R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am. J. Kidney Dis. 30, 229-236 (1997). (Pubitemid 27330339)
53. Szeto, C. C., Law, M. C., Wong, T. Y., Leung, C. B. & Li, P. K. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am. J. Kidney Dis. 37, 329-336 (2001). (Pubitemid 32116025)
54. Brimble, K. S., Walker, M., Margetts, P. J., Kundhal, K. K. & Rabbat, C. G. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J. Am. Soc. Nephrol. 17, 2591-2598 (2006). (Pubitemid 44300976)
55. Johnson, D. W. et al. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 25, 1973-1979 (2010).
56. Chung, S. H., Heimburger, O. & Lindholm, B. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern. Semin. Dial. 21, 7-10 (2008).
57. Shemin, D., Bostom, A. G., Laliberty, P. & Dworkin, L. D. Residual renal function and mortality risk in hemodialysis patients. Am. J. Kidney Dis. 38, 85-90 (2001). (Pubitemid 32611763)
58. Wang, A. Y. et al. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. J. Am. Soc. Nephrol. 15, 3134-3143 (2004). (Pubitemid 39578846)
59. Szeto, C. C. et al. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 34, 1056-1064 (1999).
60. Suda, T. et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol. Dial. Transplant. 15, 396-401 (2000). (Pubitemid 30116476)
61. Wang, A. Y. et al. Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients. Am. J. Clin. Nutr. 81, 79-86 (2005). (Pubitemid 43073378)
62. Pecoits-Filho, R. et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am. J. Kidney Dis. 41, 1212-1218 (2003). (Pubitemid 36637976)
63. Bammens, B., Evenepoel, P., Verbeke, K. & Vanrenterghem, Y. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients. Am. J. Kidney Dis. 46, 512-519 (2005). (Pubitemid 41208188)
64. Marcus, R. G., Cohl, E. & Uribarri, J. Middle molecule clearance does not influence protein intake in hemodialysis patients. Am. J. Kidney Dis. 31, 491-494 (1998). (Pubitemid 28124103)
65. Bailey, J. L. et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J. Clin. Invest. 97, 1447-1453 (1996). (Pubitemid 26097034)
66. Ballmer, P. E. et al. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J. Clin. Invest. 95, 39-45 (1995).
67. Brungger, M., Hulter, H. N. & Krapf, R. Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int. 51, 216-221 (1997). (Pubitemid 27064540)
68. Chiu, Y. W., Kopple, J. D. & Mehrotra, R. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies. Semin. Nephrol. 29, 67-74 (2009).
69. Kang, S. W. et al. Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients. Adv. Perit. Dial. 13, 249-252 (1997).
70. Kang, D. H. et al. Metabolic acidosis and composite nutritional index (CNI) in CAPD patients. Clin. Nephrol. 53, 124-131 (2000).
71. Blake, P. G. Growth hormone and malnutrition in dialysis patients. Perit. Dial. Int. 15, 210-216 (1995).
72. Fryburg, D. A., Gelfand, R. A. & Barrett, E. J. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. Physiol. 260, E499-E504 (1991).
73. Spiegel, D. M. & Breyer, J. A. Serum albumin: a predictor of long-term outcome in peritoneal dialysis patients. Am. J. Kidney Dis. 23, 283-285 (1994). (Pubitemid 24075324)
74. Han, S. H. et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit. Dial. Int. 27, 432-440 (2007). (Pubitemid 47202196)
75. Han, D. S. et al. Factors affecting low values of serum albumin in CAPD patients. Adv. Perit. Dial. 12, 288-292 (1996).
76. Goldwasser, P., Feldman, J. G. & Barth, R. H. Serum prealbumin is higher in peritoneal dialysis than in hemodialysis: a meta-analysis. Kidney Int. 62, 276-281 (2002). (Pubitemid 34754073)
77. Kalantar-Zadeh, K. & Kopple, J. D. Obesity paradox in patients on maintenance dialysis. Contrib. Nephrol. 151, 57-69 (2006). (Pubitemid 44298224)
78. Snyder, J. J., Foley, R. N., Gilbertson, D. T., Vonesh, E. F. & Collins, A. J. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 64, 1838-1844 (2003). (Pubitemid 37323715)
79. Stack, A. G., Murthy, B. V. & Molony, D. A. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int. 65, 2398-2408 (2004). (Pubitemid 38670026)
80. Enia, G. et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol. Dial. Transplant. 16, 1459-1464 (2001). (Pubitemid 32640604)
81. Abbott, K. C. et al. Body mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology? Semin. Dial. 20, 561-565 (2007).
82. McDonald, S. P., Collins, J. F. & Johnson, D. W. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J. Am. Soc. Nephrol. 14, 2894-2901 (2003). (Pubitemid 37305652)
83. Honda, H. et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am. J. Clin. Nutr. 86, 633-638 (2007). (Pubitemid 47435829)
84. Ramkumar, N., Pappas, L. M. & Beddhu, S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit. Dial. Int. 25, 461-469 (2005). (Pubitemid 41448401)
85. Bargman, J. M. The rationale and ultimate limitations of urea kinetic modelling in the estimation of nutritional status. Perit. Dial. Int. 16, 347-351 (1996). (Pubitemid 26336098)
86. Bazanelli, A. P., Kamimura, M. A., Vasselai, P., Draibe, S. A. & Cuppari, L. Underreporting of energy intake in peritoneal dialysis patients. J. Ren. Nutr. 20, 263-269 (2010).
87. Bergstrom, J. Mechanisms of uremic suppression of appetite. J. Ren. Nutr. 9, 129-132 (1999).
88. Fung, L. et al. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients. J. Am. Soc. Nephrol. 7, 737-744 (1996). (Pubitemid 27466007)
89. Williams, P., Jones, J. & Marriott, J. Do increases in dialysis dose in CAPD patients lead to nutritional improvements? Nephrol. Dial. Transplant. 9, 1841-1842 (1994).
90. Lynn, R. I., Fishbane, S. & Ginsberg, N. S. The effect of KT/V(urea) on nitrogen appearance and appetite in peritoneal dialysis. Perit. Dial. Int. 15 (Suppl. 5), S50-S52 (1995).
91. Malhotra, D. et al. Serum albumin in continuous peritoneal dialysis: its predictors and relationship to urea clearance. Kidney Int. 50, 243-249 (1996). (Pubitemid 26323719)
92. Harty, J., Boulton, H., Faragher, B., Venning, M. & Gokal, R. The influence of small solute clearance on dietary protein intake in continuous ambulatory peritoneal dialysis patients: a methodologic analysis based on cross-sectional and prospective studies. Am. J. Kidney Dis. 28, 553-560 (1996). (Pubitemid 26337595)
93. Davies, S. J., Phillips, L., Griffiths, A. M., Naish, P. F. & Russell, G. I. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int. 57, 1743-1754 (2000). (Pubitemid 30207934)
94. Paniagua, R. et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13, 1307-1320 (2002). (Pubitemid 34441412)
95. Lo, W. K. et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 64, 649-656 (2003).
96. Mak, S. K. et al. Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients. Am. J. Kidney Dis. 36, 105-114 (2000).
97. Nolph, K. D. et al. A new approach to optimizing urea clearances in hemodialysis and continuous ambulatory peritoneal dialysis. ASAIO J. 41, M446-M451 (1995).
98. Ronco, C. Adequacy of peritoneal dialysis is more than Kt/V. Nephrol. Dial. Transplant. 12 (Suppl. 1), 68-73 (1997). (Pubitemid 27105391)
99. Oreopoulos, D. G. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int. 55, 1131-1149 (1999). (Pubitemid 29100732)
100. Kawanishi, H., Moriishi, M. & Tsuchiya, S. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis. Adv. Perit. Dial. 23, 135-139 (2007).
101. Bargman, J. M., Thorpe, K. E. & Churchill, D. N. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J. Am. Soc. Nephrol. 12, 2158-2162 (2001). (Pubitemid 32880353)
102. Wang, A. Y. et al. Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dialysis. Am. J. Clin. Nutr. 77, 834-841 (2003).
103. Prasad, N. et al. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J. Ren. Nutr. 18, 195-201 (2008). (Pubitemid 351215223)
104. Martin-Del-Campo, F. et al. Conventional nutritional counselling maintains nutritional status of patients on continuous ambulatory peritoneal dialysis in spite of systemic inflammation and decrease of residual renal function. Nephrology (Carlton) 14, 493-498 (2009).
105. Sutton, D., Higgins, B. & Stevens, J. M. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels. J. Ren. Nutr. 17, 329-335 (2007). (Pubitemid 47284904)
106. Dombros, N. et al. European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. Nephrol. Dial. Transplant. 20 (Suppl. 9), ix28-ix33 (2005).
107. Blumenkrantz, M. J., Kopple, J. D., Moran, J. K. & Coburn, J. W. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 21, 849-861 (1982). (Pubitemid 12040047)
108. Fouque, D., Pelletier, S., Mafra, D. & Chauveau, P. Nutrition and chronic kidney disease. Kidney Int. 80, 348-357 (2011).
109. Shimomura, A., Tahara, D. & Azekura, H. Nutritional improvement in elderly CAPD patients with additional high protein foods. Adv. Perit. Dial. 9, 80-86 (1993).
110. Heaf, J. G., Honore, K., Valeur, D. & Randlov, A. The effect of oral protein supplements on the nutritional status of malnourished CAPD patients. Perit. Dial. Int. 19, 78-81 (1999). (Pubitemid 29184785)
111. Eustace, J. A. et al. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Kidney Int. 57, 2527-2538 (2000). (Pubitemid 30340751)
112. Aguirre Galindo, B. A. et al. Effect of polymeric diets in patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 23, 434-439 (2003). (Pubitemid 37321746)
113. Boudville, N., Rangan, A. & Moody, H. Oral nutritional supplementation increases caloric and protein intake in peritoneal dialysis patients. Am. J. Kidney Dis. 41, 658-663 (2003). (Pubitemid 36278384)
114. Teixido-Planas, J. et al. Oral protein-energy supplements in peritoneal dialysis: a multicenter study. Perit. Dial. Int. 25, 163-172 (2005). (Pubitemid 40484728)
115. Gonzalez-Espinoza, L. et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 25, 173-180 (2005). (Pubitemid 40484729)
116. Poole, R. & Hamad, A. Nutrition supplements in dialysis patients: use in peritoneal dialysis patients and diabetic patients. Adv. Perit. Dial. 24, 118-124 (2008).
117. Moretti, H. D., Johnson, A. M. & Keeling-Hathaway, T. J. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J. Ren. Nutr. 19, 298-303 (2009).
118. Inui, A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J. Clin. 52, 72-91 (2002). (Pubitemid 34256834)
119. Lien, Y. H. & Ruffenach, S. J. Low dose megestrol increases serum albumin in malnourished dialysis patients. Int. J. Artif. Organs 19, 147-150 (1996). (Pubitemid 26088524)
120. Costero, O. et al. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate. Adv. Perit. Dial. 20, 209-212 (2004).
121. Golebiewska, J. et al. Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results. Acta Biochim. Pol. 56, 733-737 (2009).
122. Boccanfuso, J. A., Hutton, M. & McAllister, B. The effects of megestrol acetate on nutritional parameters in a dialysis population. J. Ren. Nutr. 10, 36-43 (2000).
123. Park, M. S. et al. Peritoneal transport during dialysis with amino acid-based solutions. Perit. Dial. Int. 13, 280-288 (1993). (Pubitemid 23302110)
124. Garibotto, G. et al. Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure. J. Am. Soc. Nephrol. 12, 557-567 (2001). (Pubitemid 32180025)
125. Bruno, M. et al. CAPD with an amino acid dialysis solution: a long-term, cross-over study. Kidney Int. 35, 1189-1194 (1989).
126. Arfeen, S., Goodship, T. H., Kirkwood, A. & Ward, M. K. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution. Clin. Nephrol. 33, 192-199 (1990). (Pubitemid 20144337)
127. Kopple, J. D. et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 47, 1148-1157 (1995).
128. Faller, B. et al. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Nephrol. Dial. Transplant. 10, 1432-1437 (1995).
129. Chertow, G. M. et al. Laboratory surrogates of nutritional status after administration of intraperitoneal amino acid-based solutions in ambulatory peritoneal dialysis patients. J. Ren. Nutr. 3, 116-123 (1995).
130. Misra, M., Ashworth, J., Reaveley, D. A., Muller, B. & Brown, E. A. Nutritional effects of amino acid dialysate (Nutrineal) in CAPD patients. Adv. Perit. Dial. 12, 311-314 (1996).
131. Jones, M. et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am. J. Kidney Dis. 32, 761-769 (1998). (Pubitemid 28516306)
132. Taylor, G. S., Patel, V., Spencer, S., Fluck, R. J. & McIntyre, C. W. Long-term use of 1.1% amino acid dialysis solution in hypoalbuminemic continuous ambulatory peritoneal dialysis patients. Clin. Nephrol. 58, 445-450 (2002). (Pubitemid 35446916)
133. Li, F. K. et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am. J. Kidney Dis. 42, 173-183 (2003). (Pubitemid 36807667)
134. Park, M. S. et al. New insight of amino acid-based dialysis solutions. Kidney Int. Suppl. 103, S110-S114 (2006). (Pubitemid 44684785)
135. Young, G. A. et al. The use of an amino-acid-based CAPD fluid over 12 weeks. Nephrol. Dial. Transplant. 4, 285-292 (1989). (Pubitemid 19155474)
136. Dombros, N. V. et al. Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients-no effect on nutritional status. Perit. Dial. Int. 10, 79-84 (1990). (Pubitemid 20114211)
137. Dibble, J. B., Young, G. A., Hobson, S. M. & Brownjohn, A. M. Amino-acid-based continuous ambulatory peritoneal dialysis (CAPD) fluid over twelve weeks: effects on carbohydrate and lipid metabolism. Perit. Dial. Int. 10, 71-77 (1990). (Pubitemid 20114210)
138. Maurer, O. et al. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass. Clin. Nephrol. 45, 303-309 (1996). (Pubitemid 26150761)
139. Grzegorzewska, A. E., Mariak, I., Dobrowolska-Zachwieja, A. & Szajdak, L. Effects of amino acid dialysis solution on the nutrition of continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int. 19, 462-470 (1999). (Pubitemid 30015433)
140. Tjiong, H. L. et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J. Am. Soc. Nephrol. 16, 1486-1493 (2005). (Pubitemid 41716534)
141. Fouque, D., Guebre-Egziabher, F. & Laville, M. Advances in anabolic interventions for malnourished dialysis patients. J. Ren. Nutr. 13, 161-165 (2003). (Pubitemid 38368777)
142. Ikizler, T. A. et al. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int. 46, 1178-1183 (1994). (Pubitemid 24319959)
143. Kang, D. H. et al. Recombinant human growth hormone improved nutritional status of undernourished adult CAPD patients. J. Am. Soc. Nephrol. 5, 494 (1994).
144. Ikizler, T. A. et al. Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients. Kidney Int. 50, 229-234 (1996). (Pubitemid 26323717)
145. Iglesias, P. et al. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am. J. Kidney Dis. 32, 454-463 (1998). (Pubitemid 28411219)
146. Fouque, D., Peng, S. C., Shamir, E. & Kopple, J. D. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int. 57, 646-654 (2000). (Pubitemid 30430658)
147. Dombros, N. V., Digenis, G. E., Soliman, G. & Oreopoulos, D. G. Anabolic steroids in the treatment of malnourished CAPD patients: a retrospective study. Perit. Dial. Int. 14, 344-347 (1994). (Pubitemid 24338561)
148. Johansen, K. L., Mulligan, K. & Schambelan, M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 281, 1275-1281 (1999). (Pubitemid 29174478)
149. Navarro, J. F., Mora, C., Macia, M. & Garcia, J. Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int. 61, 1537-1544 (2002). (Pubitemid 34304516)
150. Aramwit, P., Palapinyo, S., Wiwatniwong, S. & Supasyndh, O. The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients. Int. J. Clin. Pharmacol. Ther. 48, 803-813 (2010).
151. Wren, A. M. et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992 (2001).
152. Wynne, K. et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J. Am. Soc. Nephrol. 16, 2111-2118 (2005). (Pubitemid 41716442)
153. Ashby, D. R. et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 76, 199-206 (2009).
154. Graham, K. A. et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int. 49, 1396-1400 (1996). (Pubitemid 26166413)
155. Stein, A. et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int. 52, 1089-1095 (1997). (Pubitemid 27435844)
156. Pickering, W. P. et al. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 61, 1286-1292 (2002). (Pubitemid 34304489)
157. Szeto, C. C., Wong, T. Y., Chow, K. M., Leung, C. B. & Li, P. K. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J. Am. Soc. Nephrol. 14, 2119-2126 (2003). (Pubitemid 36909920)
158. Montenegro, J. et al. Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions. Perit. Dial. Int. 26, 89-94 (2006). (Pubitemid 44339667)
159. Mehrotra, R. et al. Effect of high-normal compared with low-normal arterial pH on protein balances in automated peritoneal dialysis patients. Am. J. Clin. Nutr. 90, 1532-1540 (2009).